Michael Zhuang

Michael Zhuang is a Principal at Consonance Capital Partners (CCP), a New York–based private equity manager that invests exclusively in the U.S. healthcare industry. He joined the firm in 2017 as an Associate and has since been promoted, holding the title of Principal on the firm's current team page. The firm's website previously listed him at the Associate level, and third-party aggregators have variously described him as an Associate or Vice President, reflecting his progression through the firm over time.

Before joining Consonance, Michael worked as an Investment Banking Analyst in the Healthcare Group at Lazard Frères & Co., where he advised on healthcare transactions. This banking background in healthcare M&A is typical of the deal-execution pedigree CCP looks for in its investment professionals.

Michael was educated at the University of Pennsylvania, where he was a member of the selective Vagelos Life Sciences & Management (LSM) Program — a dual-degree program combining science and business. He earned a B.S. in Economics from the Wharton School and a B.A. in Biology from Penn's College of Arts and Sciences, giving him both a scientific and a financial grounding well-suited to healthcare investing.

At CCP, Michael works alongside the firm's founders — Mitchell Blutt, MD, Nancy-Ann DeParle, Benjamin Edmands, and Stephen McKenna — who previously invested together for over a decade at JPMorgan Partners (JPMP) and bring more than 90 years of combined private equity experience, primarily in healthcare.

• Healthcare only: CCP invests exclusively in U.S. middle-market healthcare companies that "add sustainable value to the healthcare system via the delivery of higher quality care at a lower cost."
• Stage & transaction types: Growth equity, leveraged buyouts, and recapitalization transactions — i.e., control and growth investments in established companies, not early-stage/seed venture.
• Target size: Companies generally with $25M–$500M in revenue, though the firm notes flexibility to invest outside that range.
• Thematic approach: The firm backs "world-class management teams to build market leaders in subsectors that have high growth opportunities," using a thematic lens on attractive healthcare segments (e.g., outpatient/specialty services, pharmacy/hospice services, healthcare IT and data, behavioral health).
• Capital base: Over $1.3 billion raised across two funds; currently investing out of Consonance Private Equity II, L.P.